Literature DB >> 4000241

Calcium absorption and achlorhydria.

R R Recker.   

Abstract

Defective absorption of calcium has been thought to exist in patients with achlorhydria. I compared absorption of calcium in its carbonate form with that in a pH-adjusted citrate form in a group of 11 fasting patients with achlorhydria and in 9 fasting normal subjects. Fractional calcium absorption was measured by a modified double-isotope procedure with 0.25 g of calcium used as the carrier. Mean calcium absorption (+/- S.D.) in the patients with achlorhydria was 0.452 +/- 0.125 for citrate and 0.042 +/- 0.021 for carbonate (P less than 0.0001). Fractional calcium absorption in the normal subjects was 0.243 +/- 0.049 for citrate and 0.225 +/- 0.108 for carbonate (not significant). Absorption of calcium from carbonate in patients with achlorhydria was significantly lower than in the normal subjects and was lower than absorption from citrate in either group; absorption from citrate in those with achlorhydria was significantly higher than in the normal subjects, as well as higher than absorption from carbonate in either group. Administration of calcium carbonate as part of a normal breakfast resulted in completely normal absorption in the achlorhydric subjects. These results indicate that calcium absorption from carbonate is impaired in achlorhydria under fasting conditions. Since achlorhydria is common in older persons, calcium carbonate may not be the ideal dietary supplement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4000241     DOI: 10.1056/NEJM198507113130202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  94 in total

1.  Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.

Authors:  M Krause; J Keller; B Beil; I van Driel; J Zustin; F Barvencik; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

Review 2.  Safety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agents.

Authors:  David A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2010-06

Review 3.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

4.  Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial.

Authors:  Matthew J Wright; Rebecca R Sullivan; Erin Gaffney-Stomberg; Donna M Caseria; Kimberly O O'Brien; Deborah D Proctor; Christine A Simpson; Jane E Kerstetter; Karl L Insogna
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

5.  Absorbability of calcium sources: the limited role of solubility.

Authors:  R P Heaney; R R Recker; C M Weaver
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

6.  Comparison of femoral morphology and bone mineral density between femoral neck fractures and trochanteric fractures.

Authors:  Yuki Maeda; Nobuhiko Sugano; Masanobu Saito; Kazuo Yonenobu
Journal:  Clin Orthop Relat Res       Date:  2010-08-20       Impact factor: 4.176

7.  The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  Laura E Targownik; William D Leslie; K Shawn Davison; David Goltzman; Sophie A Jamal; Nancy Kreiger; Robert G Josse; Stephanie M Kaiser; Christopher S Kovacs; Jerilynn C Prior; Wei Zhou
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 8.  Factors to consider in the selection of a calcium supplement.

Authors:  R F Shangraw
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

9.  Acid-suppressive medications and risk of bone loss and fracture in older adults.

Authors:  Elaine W Yu; Terri Blackwell; Kristine E Ensrud; Teresa A Hillier; Nancy E Lane; Eric Orwoll; Douglas C Bauer
Journal:  Calcif Tissue Int       Date:  2008-09-24       Impact factor: 4.333

10.  Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.

Authors:  P B Jeppesen; M Staun; L Tjellesen; P B Mortensen
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.